Encompass Health Co. (NYSE:EHC) Position Boosted by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC grew its holdings in shares of Encompass Health Co. (NYSE:EHCFree Report) by 54.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 25,930 shares of the company’s stock after purchasing an additional 9,146 shares during the period. Campbell & CO Investment Adviser LLC’s holdings in Encompass Health were worth $1,730,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. TFO Wealth Partners LLC boosted its holdings in shares of Encompass Health by 39,783.3% in the fourth quarter. TFO Wealth Partners LLC now owns 2,393 shares of the company’s stock worth $160,000 after buying an additional 2,387 shares during the period. Treasurer of the State of North Carolina boosted its holdings in shares of Encompass Health by 68.5% in the fourth quarter. Treasurer of the State of North Carolina now owns 81,452 shares of the company’s stock worth $5,434,000 after buying an additional 33,113 shares during the period. Allianz Asset Management GmbH boosted its holdings in shares of Encompass Health by 701.7% in the fourth quarter. Allianz Asset Management GmbH now owns 192,350 shares of the company’s stock worth $12,834,000 after buying an additional 168,358 shares during the period. TD Asset Management Inc boosted its holdings in shares of Encompass Health by 239.6% in the fourth quarter. TD Asset Management Inc now owns 1,969,186 shares of the company’s stock worth $131,384,000 after buying an additional 1,389,275 shares during the period. Finally, Parallel Advisors LLC boosted its holdings in shares of Encompass Health by 192.3% in the fourth quarter. Parallel Advisors LLC now owns 573 shares of the company’s stock worth $38,000 after buying an additional 377 shares during the period. Institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

EHC has been the subject of a number of research analyst reports. Barclays increased their price target on shares of Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a research report on Thursday, April 25th. Royal Bank of Canada increased their price target on shares of Encompass Health from $83.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 22nd. Mizuho increased their price target on shares of Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Thursday, April 25th. William Blair reissued an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Finally, Raymond James reissued a “strong-buy” rating and issued a $95.00 price target (up from $85.00) on shares of Encompass Health in a research report on Friday, April 26th. Eight analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $92.00.

View Our Latest Research Report on EHC

Insider Activity

In other news, CEO Mark J. Tarr sold 44,976 shares of the business’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $83.27, for a total value of $3,745,151.52. Following the sale, the chief executive officer now owns 554,098 shares in the company, valued at approximately $46,139,740.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Mark J. Tarr sold 44,976 shares of Encompass Health stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $83.27, for a total value of $3,745,151.52. Following the completion of the transaction, the chief executive officer now directly owns 554,098 shares of the company’s stock, valued at $46,139,740.46. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP John Patrick Darby sold 14,543 shares of Encompass Health stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $83.94, for a total value of $1,220,739.42. Following the completion of the transaction, the executive vice president now directly owns 84,773 shares of the company’s stock, valued at $7,115,845.62. The disclosure for this sale can be found here. In the last quarter, insiders have sold 69,519 shares of company stock worth $5,816,091. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Stock Performance

Shares of Encompass Health stock traded down $2.83 during midday trading on Monday, hitting $83.56. The company had a trading volume of 266,015 shares, compared to its average volume of 631,246. The business’s 50 day simple moving average is $83.02 and its two-hundred day simple moving average is $74.82. The stock has a market cap of $8.41 billion, a PE ratio of 23.35, a P/E/G ratio of 1.35 and a beta of 0.90. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.37. Encompass Health Co. has a 1-year low of $57.55 and a 1-year high of $87.94.

Encompass Health (NYSE:EHCGet Free Report) last posted its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $0.93 by $0.19. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The firm had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter in the previous year, the company earned $0.88 earnings per share. The business’s revenue was up 13.4% compared to the same quarter last year. As a group, equities analysts predict that Encompass Health Co. will post 4.1 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Monday, July 1st will be paid a $0.15 dividend. The ex-dividend date of this dividend is Monday, July 1st. This represents a $0.60 annualized dividend and a dividend yield of 0.72%. Encompass Health’s dividend payout ratio is presently 16.22%.

Encompass Health Company Profile

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Read More

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHCFree Report).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.